Which statement by the patient with a prostate-specific antigen (PSA) of 2.0 ng/dL indicates understanding of the 2017 recommendations regarding prostate cancer screening?

Question

Quizplus · Accepted Answer

The 2017 recommendations for prostate cancer screening suggest that men make an informed decision with their healthcare provider regarding the need for prostate cancer screening, including PSA testing. A PSA level of 2.0 ng/dL is within the normal range (typically considered to be between 0.0 and 4.0 ng/dL for most men), and annual PSA testing may be part of a monitoring strategy for some men based on their risk factors and in consultation with their healthcare provider. The other options (A, C, D) are not directly indicated by a PSA of 2.0 ng/dL alone or by the 2017 recommendations without additional context or risk factors.

Which Statement by the Patient with a Prostate-Specific Antigen (PSA)